GMMG-HD6 (#598)
Laufzeit: 01.01.2015 - 31.12.2019
imported
Kurzfassung
A randomized phase III trial on the effect of elotuzumab in VRD induction /consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma
